AIM1 PROMOTER HYPERMETHYLATION AS A PREDICTOR OF DECREASED RISK OF RECURRENCE FOLLOWING RADICAL PROSTATECTOMY

PURPOSE: To evaluate the prognostic significance of six epigenetic biomarkers (AIM1, CDH1, KIF1A, MT1G, PAK3 and RBM6 promoter hypermethlation) in a homogeneous group of prostate cancer patients, following radical prostatectomy. PATIENTS AND METHODS: Biomarker analyses were performed retrospectively...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rosenbaum, Eli, Begum, Shahnaz, Brait, Mariana, Zahurak, Marianna, Maldonado, Leonel, Eisenberger, Mario A, Epstein, Jonathan I, Partin, Alan W, Sidransky, David, Hoque, Mohammad Obaidul
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360823/
https://ncbi.nlm.nih.gov/pubmed/22127895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22461
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires